Neurological Diseases Hero Image

Neurological Diseases

These nervous system diseases affect the brain, spine and nerves. Learn how the latest advances are helping patients.

Migraine: More Than Just A Headache image

Migraine: More than Just a Bad Headache

Migraine is a debilitating neurological disease that is often misunderstood by those who do not suffer symptoms, according to the Migraine Impact Report, a new survey recently released by Eli Lilly and Company and conducted by Nielsen.

READ MORE
Taking Out ALS

Taking Out ALS

A top challenge generates a tidal wave of research and innovation.

READ MORE
Rethinking Alzheimer’s image

Rethinking Alzheimer's

New approaches to one of the world's most complex diseases are aiming to give months and years back to those facing an otherwise uncertain future.

READ MORE
Controlling MS Image

Controlling MS

The latest innovations keep MS in check.

READ MORE
Laurel Katz MS Diagnosis image

I'm Not Going to Let My MS Diagnosis Get to Me

Although most patients with multiple sclerosis (MS) are diagnosed between age 20 and 40, my story is a little different.

READ MORE
Tackling Neurological Disorders in New Ways image

Tackling Neurological Disorders in New Ways

Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.

READ MORE
8 Questions with Pat Quinn, An ALS Patient and Advocate

8 Questions with Pat Quinn, An ALS Patient and Advocate

Pat Quinn is a patient with amyotrophic lateral sclerosis or ALS.

READ MORE
Researcher Profile: Matthew Kennedy image

Researcher Profile: Matthew Kennedy

Matt has spent the majority of his nearly 20-year career in drug discovery searching for a cure to one of the most challenging diseases, Alzheimer's.

READ MORE
Researcher Profile: Pablo Sardi image

Researcher Profile: Pablo Sardi

Dr. Pablo Sardi is a Research and Development director in the Neurobiology Unit at Sanofi. He started his career in Boston doing post-doctoral research at Harvard and moved to Genzyme in 2007 to pursue his interest in investigating disease mechanism to develop therapies to treat neurodegenerative diseases.

READ MORE